Modeling shield immunity to reduce COVID-19 epidemic spread

The COVID-19 pandemic has precipitated a global crisis, with more than 1,430,000 confirmed cases and more than 85,000 confirmed deaths globally as of 9 April 2020 1 – 4 . Mitigation and suppression of new infections have emerged as the two predominant public health control strategies 5 . Both strategies focus on reducing new infections by limiting human-to-human interactions, which could be both socially and economically unsustainable in the long term. We have developed and analyzed an epidemiological intervention model that leverages serological tests 6 , 7 to identify and deploy recovered individuals 8 as focal points for sustaining safer interactions via interaction substitution, developing what we term ‘shield immunity’ at the population scale. The objective of a shield immunity strategy is to help to sustain the interactions necessary for the functioning of essential goods and services 9 while reducing the probability of transmission. Our shield immunity approach could substantively reduce the length and reduce the overall burden of the current outbreak, and can work synergistically with social distancing. The present model highlights the value of serological testing as part of intervention strategies, in addition to its well-recognized roles in estimating prevalence 10 , 11 and in the potential development of plasma-based therapies 12 – 15 . A new study models the potential effects of preferentially deploying recovered individuals, who are seropositive for anti-SARS-CoV-2 antibodies, into the community to reduce the number of interactions between susceptible and infected people, thereby limiting transmission of the virus.

[1]  C. Whittaker,et al.  Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.

[2]  Philip L. Felgner,et al.  A serological assay to detect SARS-CoV-2 seroconversion in humans , 2020, medRxiv.

[3]  D. Watts,et al.  Multiscale, resurgent epidemics in a hierarchical metapopulation model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Onder,et al.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.

[5]  M. Klompas.  Coronavirus Disease 2019 (COVID-19): Protecting Hospitals From the Invisible , 2020, Annals of Internal Medicine.

[6]  Darrell Whitley,et al.  A genetic algorithm tutorial , 1994, Statistics and Computing.

[7]  Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China , 2020, Nature Medicine.

[8]  Alan Edelman,et al.  Julia: A Fresh Approach to Numerical Computing , 2014, SIAM Rev..

[9]  D. Tyrrell,et al.  The time course of the immune response to experimental coronavirus infection of man , 1990, Epidemiology and Infection.

[10]  S. Bhatt,et al.  Report 13: Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries , 2020 .

[11]  Karline Soetaert,et al.  Inverse Modelling, Sensitivity and Monte Carlo Analysis in R Using Package FME , 2010 .

[12]  Yan Peng,et al.  Effectiveness of convalescent plasma therapy in severe COVID-19 patients , 2020, Proceedings of the National Academy of Sciences.

[13]  C. Whittaker,et al.  Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand , 2020 .

[14]  Alessandro Vespignani,et al.  Prediction and predictability of global epidemics: the role of the airline transportation network , 2005, q-bio/0507029.

[15]  Qing Nie,et al.  DifferentialEquations.jl – A Performant and Feature-Rich Ecosystem for Solving Differential Equations in Julia , 2017, Journal of Open Research Software.

[16]  Sha Lin,et al.  Serology characteristics of SARS-CoV-2 infection since the exposure and post symptoms onset , 2020, medRxiv.

[17]  Lauren Ancel Meyers,et al.  Ebola control: effect of asymptomatic infection and acquired immunity , 2014, The Lancet.

[18]  Y. Yazdanpanah,et al.  Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients , 2020, Emerging infectious diseases.

[19]  Jessica T Davis,et al.  The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak , 2020, Science.

[20]  J. Guarner,et al.  Convalescent Plasma to Treat COVID-19: Possibilities and Challenges. , 2020, JAMA.

[21]  M. Lipsitch,et al.  Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period , 2020, Science.

[22]  Charalampos Tsitouras,et al.  Runge-Kutta pairs of order 5(4) satisfying only the first column simplifying assumption , 2011, Comput. Math. Appl..

[23]  Nuno R. Faria,et al.  The effect of human mobility and control measures on the COVID-19 epidemic in China , 2020, Science.

[24]  Herman Tse,et al.  Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests , 2013, Journal of Infection.

[25]  Sang Woo Park,et al.  The time scale of asymptomatic transmission affects estimates of epidemic potential in the COVID-19 outbreak , 2020, medRxiv.

[26]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[27]  Trevor Bedford,et al.  Nextstrain: real-time tracking of pathogen evolution , 2017, bioRxiv.

[28]  Yuan Shi,et al.  Convalescent plasma as a potential therapy for COVID-19 , 2020, The Lancet Infectious Diseases.

[29]  Lei Liu,et al.  Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 , 2020, medRxiv.

[30]  Alessandro Vespignani,et al.  The role of the airline transportation network in the prediction and predictability of global epidemics , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Lipsitch,et al.  Defining the Epidemiology of Covid-19 - Studies Needed. , 2020, The New England journal of medicine.

[32]  M. Mckee,et al.  If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future , 2020, Nature Medicine.

[33]  J. Dormand,et al.  A family of embedded Runge-Kutta formulae , 1980 .

[34]  C. Hennekens,et al.  The Emerging Pandemic of Coronavirus and the Urgent Need for Public Health Leadership , 2020, American Journal of Medicine.

[35]  Michael Li,et al.  Reconciling early-outbreak estimates of the basic reproductive number and its uncertainty: framework and applications to the novel coronavirus (SARS-CoV-2) outbreak , 2020, Journal of the Royal Society Interface.

[36]  Lawrence F. Shampine,et al.  The MATLAB ODE Suite , 1997, SIAM J. Sci. Comput..

[37]  L. Meyers,et al.  When individual behaviour matters: homogeneous and network models in epidemiology , 2007, Journal of The Royal Society Interface.

[38]  R. Redfield,et al.  Covid-19 — Navigating the Uncharted , 2020, The New England journal of medicine.

[39]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[40]  Karline Soetaert,et al.  Solving Differential Equations in R: Package deSolve , 2010 .

[41]  Mahan Ghafari,et al.  Fundamental principles of epidemic spread highlight the immediate need for large-scale serological surveys to assess the stage of the SARS-CoV-2 epidemic , 2020, medRxiv.

[42]  T. Rea,et al.  Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington , 2020, The New England journal of medicine.

[43]  Michael Li,et al.  Reconciling early-outbreak estimates of the basic reproductive number and its uncertainty: framework and applications to the novel coronavirus (SARS-CoV-2) outbreak , 2020, Journal of the Royal Society Interface.

[44]  Ruiyun Li,et al.  Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2) , 2020, Science.

[45]  Alessandro Vespignani,et al.  Multiscale mobility networks and the spatial spreading of infectious diseases , 2009, Proceedings of the National Academy of Sciences.

[46]  G. Leung,et al.  Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study , 2020, The Lancet.